tiprankstipranks
Trending News
More News >
Evaxion Biotech A/S Adr (EVAX)
NASDAQ:EVAX
US Market

Evaxion Biotech (EVAX) Income Statement

Compare
403 Followers

Evaxion Biotech Income Statement

Last quarter (Q4 2025), Evaxion Biotech's total revenue was $22.04K, an increase of Infinity% from the same quarter last year. In Q4, Evaxion Biotech's net income was $-5.94M. See Evaxion Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Mar 23Dec 21
Total Revenue
$ 7.55M$ 3.34M$ 73.00K$ 0.00$ 0.00
Gross Profit
$ 7.53M$ 3.34M$ 73.00K$ 0.00$ 0.00
Operating Expenses
$ 16.76M$ 18.08M$ 22.27M$ 25.26M$ 25.83M
Depreciation and Amortization
$ 616.88K$ 607.00K$ 615.00K$ 571.00K$ 344.00K
EBITDA
$ -8.65M$ -9.79M$ -21.40M$ -22.57M$ -24.21M
Operating Income
$ -9.26M$ -14.73M$ -22.20M$ -25.26M$ -25.83M
Other Income/Expenses
$ 620.89K$ 3.38M$ -718.00K$ 1.32M$ 1.12M
Pretax Income
$ -8.64M$ -11.36M$ -22.91M$ -23.94M$ -24.71M
Net Income
$ -7.73M$ -10.57M$ -22.13M$ -23.17M$ -24.53M
Per Share Metrics
Basic EPS
$ -1.21$ -9.80$ -32.40$ -39.20$ -50.40
Diluted EPS
$ -1.21$ -9.80$ -32.40$ -39.20$ -50.40
Weighted Average Shares Outstanding
6.41M 1.07M 683.39K 590.97K 487.33K
Weighted Average Shares Outstanding (Diluted)
6.41M 1.07M 683.39K 590.97K 487.33K
Currency in USD

Evaxion Biotech Earnings and Revenue History